Eli Lilly Product offering 6.1 Segments In my opinion, Eli Lilly has a more diversified portfolio right now than Novo Nordisk
, , GHK-Cu + TB-500 : GHK-Cu + CJC-1295 + : GH + / GHK-Cu GHK-Cu + + : long-term GHK-Cu + KPV + BPC-157 : vs GHK-Cu - STbio , , , +2+8 C (), ( ) (1015 )
It's just like, no, like welcome to like 10,000 people who are just just like you
Additionally, while some consumers may offset drug costs to some extent, their relatively high prices could discourage larger purchases, notably in categories like furniture and travel expenses
August 2, 2025
Although MOTS-C has gained attention in wellness and longevity spaces, it is not FDA-approved for improving metabolism, enhancing exercise performance, boosting energy, supporting weight management, or treating any medical condition